Research on NOAF is difficult because different studies define it in different ways and measure different outcomes. This makes it hard to compare treatments and find the best ways to prevent or manage NOAF.
The COS-ABACUS study aims to create a Core Outcome Set (COS) – a standard list of outcomes that all future NOAF studies should measure. This will help researchers compare treatments, improve research quality, and focus on outcomes that matter most to patients.
How Will This Study Be Done?
The research will be carried out in five stages:
- Reviewing past research – The team will look at published studies, doctor surveys, and patient feedback to see what outcomes have been measured before.
- Expert and patient ranking of outcomes – Using an online survey (e-Delphi method), doctors, researchers, and patients will score the importance of different outcomes on a scale from 1-9. They can also suggest new outcomes.
- Finding the best ways to measure outcomes – The team will review existing research to see which measurement tools (Outcome Measurement Instruments, OMIs) are best for tracking NOAF-related outcomes. Experts will then meet to discuss and agree on the most reliable ways to measure them.
- Final agreement on core outcomes and how to measure them – In a final discussion, experts and patients will work together to agree on the most important outcomes and how they should be measured in future research.
- Sharing the results – The study’s findings will be published in scientific journals, presented at conferences, and shared with doctors, researchers, and patient groups worldwide.
Who is Involved?
This project brings together a wide range of experts, including intensive care doctors, heart specialists (cardiologists), researchers, and epidemiologists. Importantly, patients who have had NOAF or a critical illness will be actively involved to ensure that the outcomes chosen reflect what matters most to those affected.
What Will This Study Achieve?
By creating a standard set of outcomes for NOAF research, COS-ABACUS will:
- Make it easier to compare studies and treatments.
- Ensure research focuses on the most important patient outcomes.
- Help guide the development of better treatment guidelines for NOAF.
In the future, these results could improve how NOAF is prevented and treated, benefiting both patients and healthcare providers.
Ethical Approval
The study has been granted approval by the University of Liverpool Ethics Committee (Ref: 11256. 21/06/2022). The results will be shared widely to improve future research and patient care.